ERAL1 and breast cancer: Other types of modifications of ERα, which include acetylation, methylation, ubiquitination and SUMOylation (Ascenzi et al. 2006, Le Romancer et al. 2011), may also affect the sensitivity of breast cancer cells to AEs.